ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0913

Systemic Sclerosis Portends a Higher Risk of Conduction and Rhythm Disorders at Diagnosis and During Disease Course: Results from a US Population Based Study

Yasser Radwan1, Reto Kurmann2, Avneek Singh Sandhu3, Edward El-Am4, Cynthia Crowson2, Eric Matteson5, Thomas Osborn2, Kenneth Warrington6, Rekha Mankad2 and Ashima Makol2, 1Mayo Clinic, Rochester, Minnesota, USA, Lansing, MI, 2Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN, 3Mayo Clinic, Rochester, Minnesota, USA, Dayton, OH, 4Indiana University School of Medicine, Indianapolis, IN, 5Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA, Rochester, MN, 6Mayo Clinic, Rochester, MN

Meeting: ACR Convergence 2020

Keywords: Cardiovascular, Scleroderma, Systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Systemic Sclerosis & Related Disorders – Clinical Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Cardiac involvement, including electrocardiogram (ECG) abnormalities, is associated with worse prognosis in systemic sclerosis (SSc). We studied the incidence, risk factors and outcomes of conduction and rhythm disorders in a population-based cohort of patients with SSc and non-SSc comparators from the same geographic area.

Methods: A previously identified incident cohort of SSc patients (1980-2016) in a well-defined geographic area was compared to a randomly selected 2:1 cohort of age- and sex-matched non-SSc subjects from the same population base. Demographics, disease characteristics, cardiovascular risk factors and laboratory tests were abstracted by manual record review. ECGs and Holter ECGs were reviewed to determine the occurrence of any conduction or rhythm abnormalities. The need for cardiac interventions was also abstracted.

Results: 78 incident SSc cases and 156 non-SSc comparators were identified [age 56 years± 15.7, 91% female]. Prevalence of any conduction disorders before SSc diagnosis compared to non-SSc comparators was 15% vs. 7% (p=0.06), and any rhythm disorder was 18% vs. 13% (p=0.33). During a median follow up of 10.5 years in patients with SSc and 13.0 years in non-SSc comparators, conduction disorders developed in 25 SSc patients with a cumulative incidence (ci) of 20.5% (95% CI: 12.4-34.1%) compared to 28 non-SSc patients with ci of 10.4% (95% CI: 6.2-17.4%) (HR: 2.57; 95% CI: 1.48-4.45), while rhythm disorders developed in 27 SSc patients with ci of 27.3% (95% CI: 17.9-41.6%) vs 43 non-SSc patients with ci of 18.0% (95% CI: 12.3-26.4%) (HR: 1.62; 95% CI: 1.00-2.64). (Figure 1)

Conduction disorders in patients with SSc during follow up included: 1st-degree atrioventricular block (AVB) (n=12), 2nd-degree AVB (n=1), 3rd-degree AVB (n=1), right bundle branch block (n=10), left bundle branch block (n=4), bifascicular block (n=6), and prolonged-QT (n=13). Rhythm disorders included: atrial fibrillation (n=10), atrial flutter (n=4), supraventricular tachycardia (n=4), ventricular tachycardia (n=1), and premature ventricular contractions (n=16).

ECG, Holter ECG, and cardiac interventions are presented in Table 1. Pulmonary hypertension (PHT) was the only significant risk factor identified for development of both conduction and rhythm disorders, while current smoking was a significant risk factor for development of rhythm disorders only (Table 2). Conduction and rhythm disorders were associated with increased mortality among patients with SSc (HR=7.60, 95% CI: 3.49-16.55 and HR=4.87, 95% CI: 2.28-10.42, respectively, after adjusting for age, sex and calendar year of diagnosis).

Conclusion: Patients with SSc have a significantly higher prevalence of conduction disorders at disease onset than non-SSc comparators. During the course of their disease, their risk of developing conduction disorders is 2.6-fold, and risk of rhythm disorders is 1.6-fold increased, compared to non-SSc subjects. Our study findings warrant increased vigilance and screening for ECG abnormalities in patients with SSc who have PHT. Underlying mechanisms for this association require further elucidation.

Figure 1: Cumulative incidence of any conduction or any rhythm disorder in systemic sclerosis (SSc) (solid line) vs non-SSc comparators (dashed line).

Table 1. Cumulative incidence of conduction and rhythm disorders in 78 patients with systemic sclerosis (SSc) compared with 156 non-SSc comparators

Table 2. Risk factors at systemic sclerosis (SSc) diagnosis for conduction and rhythm disorders in 64 SSc patients without these disorders at disease onset


Disclosure: Y. Radwan, None; R. Kurmann, None; A. Sandhu, None; E. El-Am, None; C. Crowson, Myriad Genetics, 1, Pfizer, 1; E. Matteson, Boehringer Ingelheim, 5, Gilead, 5, TympoBio, 5, Arena Pharmaceuticals, 5, Up-to-date, 7, Simply Speaking, 8; T. Osborn, None; K. Warrington, Lilly, 2, Kiniksa, 2; R. Mankad, None; A. Makol, None.

To cite this abstract in AMA style:

Radwan Y, Kurmann R, Sandhu A, El-Am E, Crowson C, Matteson E, Osborn T, Warrington K, Mankad R, Makol A. Systemic Sclerosis Portends a Higher Risk of Conduction and Rhythm Disorders at Diagnosis and During Disease Course: Results from a US Population Based Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/systemic-sclerosis-portends-a-higher-risk-of-conduction-and-rhythm-disorders-at-diagnosis-and-during-disease-course-results-from-a-us-population-based-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systemic-sclerosis-portends-a-higher-risk-of-conduction-and-rhythm-disorders-at-diagnosis-and-during-disease-course-results-from-a-us-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology